Categories: News

Woxsen University Claims Its Spot Among India’s Best Universities in Outlook-ICARE Rankings 2025

HYDERABAD, India, Aug. 4, 2025 /PRNewswire/ — Woxsen University has achieved significant recognition in the Outlook-ICARE Rankings 2025, securing Rank #7 among All-India State Private Universities and Rank #3 in Practice–Integrated Multi–Disciplinary Universities. These rankings affirm Woxsen’s standing as one of India’s most forward-thinking and impactful institutions in higher education.

- Advertisement -

Woxsen’s rise in the national rankings is attributed to its academic model, which integrates classroom learning with real-world application, global perspectives, and cross-disciplinary collaboration. The university continues to pioneer new approaches to education, focusing on experiential learning, research-led teaching, and strong industry engagement.

- Advertisement -

Woxsen University offers an education that is rigorous, relevant, and future-ready—shaped by a strong academic foundation, industry alignment, and a global perspective. The university’s emphasis on innovation, entrepreneurship, and leadership development that ensures its graduates are well-prepared to thrive in dynamic global environments.

- Advertisement -

The Outlook-ICARE Rankings 2025 serve as a strong validation of Woxsen’s commitment to academic excellence, global relevance, and a purpose-driven educational ecosystem. As the university continues to grow its influence nationally and internationally, this recognition marks another key milestone in its journey.

- Advertisement -

About Woxsen University, Hyderabad:

- Advertisement -

Woxsen University, located in Hyderabad, is one of the first private universities in the state of Telangana, India. Renowned for its 200-acre state-of-the-art campus and infrastructure, Woxsen University offers new-age, disruptive programs in the fields of Business, Technology, Arts & Design, Architecture, Law, and Liberal Arts & Humanities. Woxsen also houses Asia’s largest Sports Infrastructure, spread over 60 acres. With 170+ Global Partner Universities and a strong industry connect, Woxsen is recognized as one of the top universities for Academic Excellence and Global Edge. Woxsen has also secured the QS Business Masters World Ranking 2025, Rank #9 All India, Top 100 B-Schools by Times B-School Ranking 2025, Rank #6, Asia Pacific, Bloomberg Best B-School, and features in India’s Best B-Schools beyond IIMs by Dalal Street Investment Journal 2025, in 4th consecutive year. Woxsen is ranked as one of the Top Professional Colleges in India by Outlook I-CARE for its undergraduate programs, securing All India Rank 12 among the Top 130 BBA Private Institutes, All India Rank 20 among the Top 160 B.Tech Private Institutes, All India Rank 3 among the Top 25 Design Private Institutes, and All India Rank 3 among the Top 30 B.Arch Private Institutes. 

- Advertisement -

Photo: https://mma.prnewswire.com/media/2743317/Woxsen_ICARE_2025.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/woxsen-university-claims-its-spot-among-indias-best-universities-in-outlook-icare-rankings-2025-302520493.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

5 minutes ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

5 minutes ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

5 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

6 minutes ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

6 minutes ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

6 minutes ago